查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2036023

2026年全球奈米抗體診斷市場報告

Nanobody-Based Diagnostics Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，基於奈米抗體的診斷市場發展迅速。預計該市場規模將從2025年的11.3億美元成長到2026年的12.7億美元，複合年成長率（CAGR）為12.7%。過去幾年成長要素包括抗體工程技術的進步、感染疾病的蔓延、癌症診斷需求的成長、免疫診斷領域研究經費的增加以及快速診斷平台的普及。

預計未來幾年，基於奈米抗體的診斷市場將快速成長，到2030年將達到20.7億美元，複合年成長率（CAGR）為13.0%。預測期內的成長預計將受到以下因素的推動：對精準診斷的需求不斷成長、基於人工智慧的診斷工具整合技術的進步、微流體感測器系統的日益普及、分散式診斷檢測的擴展以及對用於疾病早期檢測的生物標記的日益關注。預測期內的關鍵趨勢包括：側向流動奈米抗體檢測方法的廣泛應用、對高親和性單域抗體試劑需求的成長、奈米抗體在照護現場診斷中的應用擴展、多生物標記檢測平台的發展以及基於奈米抗體的成像技術在疾病監測中的應用日益廣泛。

預計未來幾年，感染疾病的日益普及將推動基於奈米抗體的診斷市場擴張。感染疾病是由細菌、病毒、真菌和寄生蟲等有害微生物引起的疾病，可透過人與人之間的接觸或接觸受污染的環境傳播。感染疾病流行率的上升主要是由於人與人之間的密切接觸，這促進了病原體在社區內的傳播。使用奈米抗體的診斷方法能夠快速、高特異性和高靈敏度地檢測病原體，從而實現早期診斷和及時治療，進而有助於疾病控制和改善患者預後。例如，美國疾病管制與預防中心（CDC）在2024年3月報告稱，結核病病例數從2022年的8320例增加到2023年的9615例，增加了1295例。因此，感染疾病流行率的上升正在推動基於奈米抗體的診斷市場的成長。

在奈米抗體診斷市場中，領先企業正致力於開發創新解決方案，例如先進的奈米抗體平台，以提高疾病檢測的準確性和速度。先進的奈米抗體平台利用高度特異性、穩定性強、體積小、單域的抗體，這些抗體比傳統抗體更快穿透組織，更好地標靶化疾病生物標記物，並增強診斷和治療效果。例如，2025年9月，總部位於澳洲的放射性藥物公司Cyclotek Pty Ltd獲得了澳洲政府第16期CRC-P津貼，用於推動基於奈米抗體的癌症治療診斷學平台的開發。該計畫與墨爾本大學、Revela Bio Inc.以及多家當地中小企業合作開展，重點開發利用奈米抗體診療技術靶向成纖維母細胞激活蛋白（FAP）的診斷和治療藥物。 FAP是一種在肺癌、胰臟癌和卵巢癌等侵襲性癌症中高表現的生物標記。基於奈米抗體的療法結合了抗體的精準定向和小分子的藥物動力學特性，使其成為診斷成像和治療應用的理想選擇。該舉措旨在開發先進的放射性標記化學技術，進行臨床前評估，並最終啟動首次人體臨床試驗，使Cyclotek Pty Ltd公司能夠在澳洲、紐西蘭以及更廣泛的亞太地區拓展並商業化這項創新平台。

目錄

第1章：執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球奈米抗體診斷市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略適宜性評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 清單：主要原料、資源和供應商
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章：全球市場趨勢與策略

  • 關鍵科技與未來趨勢
    • 生物技術、基因組學和精準醫療
    • 人工智慧和自主智慧
    • 數位化、雲端運算、巨量資料、網路安全
    • 工業4.0和智慧製造
    • 擴展客製化資料擷取解決方案，以滿足小眾資料需求。
  • 主要趨勢
    • 側向流動奈米抗體檢測方法的應用日益廣泛
    • 對高親和性單域抗體試劑的需求日益成長
    • 擴大奈米抗體在即時診斷的應用。
    • 多生物標記檢測平台的擴展
    • 擴大奈米抗體影像技術在疾病監測的應用

第5章 終端用戶產業市場分析

  • 醫院和診所
  • 診斷檢查室
  • 研究機構
  • 製藥和生物技術公司
  • 大學醫院

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及 COVID-19 疫情對市場的影響。

第7章：全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球奈米抗體診斷市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 全球奈米抗體診斷市場：規模、對比及成長率分析
  • 全球奈米抗體診斷市場表現：規模與成長，2020-2025年
  • 全球奈米抗體診斷市場預測：規模與成長，2025-2030年，2035年

第8章：全球市場總規模（TAM）

第9章 市場細分

  • 透過技術
  • 免疫檢測、分子診斷、基於生物感測器的檢測、螢光和成像診斷
  • 依產品類型
  • 試劑、試劑盒、儀器及其他產品類型
  • 透過使用
  • 感染疾病、腫瘤學、自體免疫疾病、心血管疾病及其他應用
  • 最終用戶
  • 醫院、診所、診斷檢測實驗室、研究機構和其他最終用戶
  • 細分（按類型）：免疫檢測
  • 酵素免疫分析法、蛋白質印跡法、橫向流動化驗、免疫測量
  • 細分：依類型：分子診斷
  • 基於聚合酵素鏈鎖反應(PCR) 的檢測方法、核酸雜合反應、次世代定序、等溫擴增方法
  • 細分（按類型）：使用生物感測器進行檢測
  • 電化學生物感測器、光學生物感測器、壓電感測器、微流體生物感測器
  • 細分（按類型）：螢光和影像診斷
  • 螢光顯微鏡、流式細胞技術、螢光原位雜合反應、分子成像技術

第10章 區域與國別分析

第11章 亞太市場

第12章：中國市場

第13章：印度市場

第14章：日本市場

第15章：澳洲市場

第16章：印尼市場

第17章：韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章 西歐市場

第21章英國市場

第22章：德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章：東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章：南美市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 基於奈米抗體的診斷市場：競爭格局與市場佔有率，2024 年
  • 基於奈米抗體的診斷市場：公司評估矩陣
  • 基於奈米抗體的診斷市場：公司簡介
    • Sanofi SA
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Agilent Technologies Inc.
    • PerkinElmer Inc.

第37章 其他大型企業和創新企業

  • Bruker Corporation, Bio-Rad Laboratories Inc., GenScript Biotech Corporation, Biocytogen LLC, Sino Biological Inc., Abzena plc, NanoTemper Technologies GmbH, RayBiotech Inc., Proteintech Group Inc., Creative Biolabs Inc., Isogenica Ltd., Beroni Group Limited, Immudex ApS, Cyclotek Pty Ltd, NanoTag Biotechnologies GmbH

第38章：全球市場競爭基準分析與儀錶板

第39章：預計進入市場的新創企業

第40章 重大併購

第41章 具有高市場潛力的國家、細分市場與策略

  • 2030年奈米抗體診斷市場：提供新機會的國家
  • 奈米抗體診斷市場展望（2030）：新興細分市場機會
  • 奈米抗體診斷市場展望（2030 年）：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第42章附錄

簡介目錄
Product Code: HS5MNBDA01_G26Q2

Nanobody-based diagnostics use single-domain antibodies derived from camelids, which are smaller, highly stable, and extremely specific compared to traditional antibodies. These nanobodies efficiently bind to target molecules, allowing sensitive and rapid detection of biomolecules or pathogens, and are widely applied in diagnostic assays and imaging.

The key technologies of nanobody-based diagnostics include immunoassays, molecular diagnostics, biosensor-based detection, and fluorescence and imaging diagnostics. Immunoassays are laboratory techniques that detect or quantify specific molecules, such as proteins or hormones, using antibodies or antigens. Product types include reagents, kits, instruments, and other variants. Applications cover infectious diseases, oncology, autoimmune disorders, cardiovascular diseases, and other areas, with end users including hospitals and clinics, diagnostic laboratories, research institutes, and other sectors.

Tariffs on imported laboratory reagents, diagnostic instruments, and specialty biomolecule production materials are impacting the nanobody-based diagnostics market by increasing manufacturing and procurement costs, particularly affecting reagents, kits, and biosensor-based detection segments. Regions such as North America and Europe that rely on cross-border supply chains for advanced laboratory components are most affected. Higher costs may slow adoption in hospitals and diagnostic laboratories; however, tariffs are also encouraging domestic production of recombinant nanobodies and localized assay kit manufacturing, strengthening regional supply resilience and innovation capacity.

The nanobody-based diagnostics market research report is one of a series of new reports from The Business Research Company that provides nanobody-based diagnostics market statistics, including nanobody-based diagnostics industry global market size, regional shares, competitors with a nanobody-based diagnostics market share, detailed nanobody-based diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the nanobody-based diagnostics industry. This nanobody-based diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The nanobody-based diagnostics market size has grown rapidly in recent years. It will grow from $1.13 billion in 2025 to $1.27 billion in 2026 at a compound annual growth rate (CAGR) of 12.7%. The growth in the historic period can be attributed to advancements in antibody engineering technologies, increasing prevalence of infectious diseases, growth in cancer diagnostics demand, rising research funding in immunodiagnostics, expansion of rapid diagnostic testing platforms.

The nanobody-based diagnostics market size is expected to see rapid growth in the next few years. It will grow to $2.07 billion in 2030 at a compound annual growth rate (CAGR) of 13.0%. The growth in the forecast period can be attributed to growing demand for precision diagnostics, increasing integration of AI-based assay analysis tools, rising adoption of microfluidic biosensor systems, expansion of decentralized diagnostic testing, increasing focus on early disease detection biomarkers. Major trends in the forecast period include increasing adoption of lateral flow nanobody assays, rising demand for high-affinity single-domain antibody reagents, growing integration of nanobodies in point-of-care diagnostics, expansion of multiplexed biomarker detection platforms, rising use of nanobody-based imaging in disease monitoring.

The rising prevalence of infectious diseases is anticipated to drive the expansion of the nanobody-based diagnostics market in the coming years. Infectious diseases are illnesses caused by harmful microorganisms, including bacteria, viruses, fungi, or parasites, which can be transmitted from person to person or through contact with contaminated environments. The increase in infectious disease prevalence is largely due to closer human interactions, which facilitate the spread of pathogens within communities. Nanobody-based diagnostics offer rapid, highly specific, and sensitive detection of infectious agents, allowing for early diagnosis and timely treatment, thereby helping to control disease spread and enhance patient outcomes. For example, in March 2024, the Centers for Disease Control and Prevention, a US-based government agency, reported that tuberculosis cases increased from 8,320 in 2022 to 9,615 in 2023, marking a rise of 1,295 cases. Thus, the growing prevalence of infectious diseases is supporting the growth of the nanobody-based diagnostics market.

Key companies operating in the nanobody-based diagnostics market are focusing on developing innovative solutions such as, advanced nanobody platforms to improve the accuracy and speed of disease detection. Advanced nanobody platforms use small, single-domain antibodies that are highly specific and stable, enabling faster tissue penetration, improved targeting of disease biomarkers, and enhanced diagnostic and therapeutic effectiveness compared to conventional antibodies. For example, in September 2025, Cyclotek Pty Ltd, an Australia-based radiopharmaceutical company, was awarded a CRC-P Round 16 grant by the Australian Government to advance a nanobody-based theranostic platform for cancer. In collaboration with the University of Melbourne, Revela Bio Inc., and several local SMEs, the project focuses on developing targeted diagnostics and therapeutics that leverage nanobodies against the Fibroblast Activation Protein (FAP), a biomarker highly expressed in aggressive cancers such as lung, pancreatic, and ovarian cancer. Nanobodies combine the precision targeting of antibodies with the pharmacokinetics of small molecules, making them ideal for both diagnostic imaging and therapeutic applications. The initiative aims to develop advanced radiolabelling chemistry, conduct pre-clinical evaluations, and progress to first-in-human clinical trials, positioning Cyclotek Pty Ltd to scale and commercialize this innovative platform across Australia, New Zealand, and the broader Asia-Pacific region.

The rising healthcare investments are expected to further propel the expansion of the nanobody-based diagnostics market. Healthcare investments involve the allocation of financial resources by governments, organizations, and healthcare providers to enhance medical infrastructure, services, technology, and overall healthcare delivery. These investments are increasing due to heightened demand for advanced medical services and modern technologies that improve patient care and health outcomes. Such investments facilitate the development and adoption of nanobody-based diagnostics by funding advanced research, upgrading laboratory infrastructure, and enabling healthcare providers to implement cutting-edge diagnostic technologies for more accurate and timely disease detection. For instance, in January 2026, the Centers for Medicare & Medicaid Services, a US-based government agency, reported that Medicare spending in 2024 grew by 7.8%, reaching $1,118.0 billion and accounting for 21% of total national health expenditures (NHE), while Medicaid spending increased by 6.6% to $931.7 billion, representing 18% of total NHE. Therefore, increasing healthcare investments are contributing to the growth of the nanobody-based diagnostics market.

Major companies operating in the nanobody-based diagnostics market are Sanofi S.A., Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., PerkinElmer Inc., Bruker Corporation, Bio-Rad Laboratories Inc., GenScript Biotech Corporation, Biocytogen LLC, Sino Biological Inc., Abzena plc, NanoTemper Technologies GmbH, RayBiotech Inc., Proteintech Group Inc., Creative Biolabs Inc., Isogenica Ltd., Beroni Group Limited, Immudex ApS, Cyclotek Pty Ltd, NanoTag Biotechnologies GmbH.

North America was the largest region in the nanobody-based diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nanobody-based diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the nanobody-based diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The nanobody-based diagnostics market consists of revenues earned by entities by providing services such as biomarker detection, assay development, immunodiagnostic testing, molecular diagnostics support, and research-grade diagnostic solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. The nanobody-based diagnostics market includes sales of nanobody-based assay kits, biosensors, diagnostic reagents, imaging probes, and targeted detection platforms. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Nanobody-Based Diagnostics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses nanobody-based diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for nanobody-based diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The nanobody-based diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Technology: Immunoassays; Molecular Diagnostics; Biosensor-Based Detection; Fluorescence And Imaging Diagnostics
  • 2) By Product Type: Reagents; Kits; Instruments; Other Product Types
  • 3) By Application: Infectious Diseases; Oncology; Autoimmune Disorders; Cardiovascular Diseases; Other Applications
  • 4) By End-User: Hospitals And Clinics; Diagnostic Laboratories; Research Institutes; Other End Users
  • Subsegments:
  • 1) By Immunoassays: Enzyme Linked Immunosorbent Assay; Western Blotting; Lateral Flow Assay; Radioimmunoassay
  • 2) By Molecular Diagnostics: Polymerase Chain Reaction Based Assays; Nucleic Acid Hybridization; Next Generation Sequencing; Isothermal Amplification Techniques
  • 3) By Biosensor Based Detection: Electrochemical Biosensors; Optical Biosensors; Piezoelectric Biosensors; Microfluidic Biosensors
  • 4) By Fluorescence and Imaging Diagnostics: Fluorescence Microscopy; Flow Cytometry; Fluorescence In Situ Hybridization; Molecular Imaging Techniques
  • Companies Mentioned: Sanofi S.A.; Thermo Fisher Scientific Inc.; Merck KGaA; Agilent Technologies Inc.; PerkinElmer Inc.; Bruker Corporation; Bio-Rad Laboratories Inc.; GenScript Biotech Corporation; Biocytogen LLC; Sino Biological Inc.; Abzena plc; NanoTemper Technologies GmbH; RayBiotech Inc.; Proteintech Group Inc.; Creative Biolabs Inc.; Isogenica Ltd.; Beroni Group Limited; Immudex ApS; Cyclotek Pty Ltd; NanoTag Biotechnologies GmbH.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Nanobody-Based Diagnostics Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Nanobody-Based Diagnostics Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Nanobody-Based Diagnostics Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Nanobody-Based Diagnostics Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Lateral Flow Nanobody Assays
    • 4.2.2 Rising Demand For High-Affinity Single-Domain Antibody Reagents
    • 4.2.3 Growing Integration Of Nanobodies In Point-Of-Care Diagnostics
    • 4.2.4 Expansion Of Multiplexed Biomarker Detection Platforms
    • 4.2.5 Rising Use Of Nanobody-Based Imaging In Disease Monitoring

5. Nanobody-Based Diagnostics Market Analysis Of End Use Industries

  • 5.1 Hospitals And Clinics
  • 5.2 Diagnostic Laboratories
  • 5.3 Research Institutes
  • 5.4 Pharmaceutical And Biotechnology Companies
  • 5.5 Academic Medical Centers

6. Nanobody-Based Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Nanobody-Based Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Nanobody-Based Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Nanobody-Based Diagnostics Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Nanobody-Based Diagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Nanobody-Based Diagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Nanobody-Based Diagnostics Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Nanobody-Based Diagnostics Market Segmentation

  • 9.1. Global Nanobody-Based Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Immunoassays, Molecular Diagnostics, Biosensor-Based Detection, Fluorescence And Imaging Diagnostics
  • 9.2. Global Nanobody-Based Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Reagents, Kits, Instruments, Other Product Types
  • 9.3. Global Nanobody-Based Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Infectious Diseases, Oncology, Autoimmune Disorders, Cardiovascular Diseases, Other Applications
  • 9.4. Global Nanobody-Based Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Other End Users
  • 9.5. Global Nanobody-Based Diagnostics Market, Sub-Segmentation Of Immunoassays, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Enzyme Linked Immunosorbent Assay, Western Blotting, Lateral Flow Assay, Radioimmunoassay
  • 9.6. Global Nanobody-Based Diagnostics Market, Sub-Segmentation Of Molecular Diagnostics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Polymerase Chain Reaction Based Assays, Nucleic Acid Hybridization, Next Generation Sequencing, Isothermal Amplification Techniques
  • 9.7. Global Nanobody-Based Diagnostics Market, Sub-Segmentation Of Biosensor Based Detection, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Electrochemical Biosensors, Optical Biosensors, Piezoelectric Biosensors, Microfluidic Biosensors
  • 9.8. Global Nanobody-Based Diagnostics Market, Sub-Segmentation Of Fluorescence And Imaging Diagnostics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Fluorescence Microscopy, Flow Cytometry, Fluorescence In Situ Hybridization, Molecular Imaging Techniques

10. Nanobody-Based Diagnostics Market Regional And Country Analysis

  • 10.1. Global Nanobody-Based Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Nanobody-Based Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Nanobody-Based Diagnostics Market

  • 11.1. Asia-Pacific Nanobody-Based Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Nanobody-Based Diagnostics Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Nanobody-Based Diagnostics Market

  • 12.1. China Nanobody-Based Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Nanobody-Based Diagnostics Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Nanobody-Based Diagnostics Market

  • 13.1. India Nanobody-Based Diagnostics Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Nanobody-Based Diagnostics Market

  • 14.1. Japan Nanobody-Based Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Nanobody-Based Diagnostics Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Nanobody-Based Diagnostics Market

  • 15.1. Australia Nanobody-Based Diagnostics Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Nanobody-Based Diagnostics Market

  • 16.1. Indonesia Nanobody-Based Diagnostics Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Nanobody-Based Diagnostics Market

  • 17.1. South Korea Nanobody-Based Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Nanobody-Based Diagnostics Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Nanobody-Based Diagnostics Market

  • 18.1. Taiwan Nanobody-Based Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Nanobody-Based Diagnostics Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Nanobody-Based Diagnostics Market

  • 19.1. South East Asia Nanobody-Based Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Nanobody-Based Diagnostics Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Nanobody-Based Diagnostics Market

  • 20.1. Western Europe Nanobody-Based Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Nanobody-Based Diagnostics Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Nanobody-Based Diagnostics Market

  • 21.1. UK Nanobody-Based Diagnostics Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Nanobody-Based Diagnostics Market

  • 22.1. Germany Nanobody-Based Diagnostics Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Nanobody-Based Diagnostics Market

  • 23.1. France Nanobody-Based Diagnostics Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Nanobody-Based Diagnostics Market

  • 24.1. Italy Nanobody-Based Diagnostics Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Nanobody-Based Diagnostics Market

  • 25.1. Spain Nanobody-Based Diagnostics Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Nanobody-Based Diagnostics Market

  • 26.1. Eastern Europe Nanobody-Based Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Nanobody-Based Diagnostics Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Nanobody-Based Diagnostics Market

  • 27.1. Russia Nanobody-Based Diagnostics Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Nanobody-Based Diagnostics Market

  • 28.1. North America Nanobody-Based Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Nanobody-Based Diagnostics Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Nanobody-Based Diagnostics Market

  • 29.1. USA Nanobody-Based Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Nanobody-Based Diagnostics Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Nanobody-Based Diagnostics Market

  • 30.1. Canada Nanobody-Based Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Nanobody-Based Diagnostics Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Nanobody-Based Diagnostics Market

  • 31.1. South America Nanobody-Based Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Nanobody-Based Diagnostics Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Nanobody-Based Diagnostics Market

  • 32.1. Brazil Nanobody-Based Diagnostics Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Nanobody-Based Diagnostics Market

  • 33.1. Middle East Nanobody-Based Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Nanobody-Based Diagnostics Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Nanobody-Based Diagnostics Market

  • 34.1. Africa Nanobody-Based Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Nanobody-Based Diagnostics Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Nanobody-Based Diagnostics Market Regulatory and Investment Landscape

36. Nanobody-Based Diagnostics Market Competitive Landscape And Company Profiles

  • 36.1. Nanobody-Based Diagnostics Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Nanobody-Based Diagnostics Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Nanobody-Based Diagnostics Market Company Profiles
    • 36.3.1. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Nanobody-Based Diagnostics Market Other Major And Innovative Companies

  • Bruker Corporation, Bio-Rad Laboratories Inc., GenScript Biotech Corporation, Biocytogen LLC, Sino Biological Inc., Abzena plc, NanoTemper Technologies GmbH, RayBiotech Inc., Proteintech Group Inc., Creative Biolabs Inc., Isogenica Ltd., Beroni Group Limited, Immudex ApS, Cyclotek Pty Ltd, NanoTag Biotechnologies GmbH

38. Global Nanobody-Based Diagnostics Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Nanobody-Based Diagnostics Market

41. Nanobody-Based Diagnostics Market High Potential Countries, Segments and Strategies

  • 41.1 Nanobody-Based Diagnostics Market In 2030 - Countries Offering Most New Opportunities
  • 41.2 Nanobody-Based Diagnostics Market In 2030 - Segments Offering Most New Opportunities
  • 41.3 Nanobody-Based Diagnostics Market In 2030 - Growth Strategies
    • 41.3.1 Market Trend Based Strategies
    • 41.3.2 Competitor Strategies

42. Appendix

  • 42.1. Abbreviations
  • 42.2. Currencies
  • 42.3. Historic And Forecast Inflation Rates
  • 42.4. Research Inquiries
  • 42.5. The Business Research Company
  • 42.6. Copyright And Disclaimer